2020 annual financial data
Inhibikase Therapeutics 2020 Operating margin
Inhibikase Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was -403.52%.
Operating income was -2,818,492 USD and net income was -2,877,296 USD.
Operating cash flow was -1,129,355 USD.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 698,468 USD
- Operating income
- -2,818,492 USD
- Net income
- -2,877,296 USD
- Operating cash flow
- -1,129,355 USD